Key statistics
On Tuesday, Brainstorm Cell Therapeutics Inc (GHD:BER) closed at 0.00, -100.00% above its 52-week low of 2.34, set on Dec 12, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 0.00 |
Low | 0.00 |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | 5.32m |
Free float | 4.84m |
P/E (TTM) | -- |
Market cap | 6.59m USD |
EPS (TTM) | -3.46 USD |
Data delayed at least 15 minutes, as of Oct 01 2024 07:39 BST.
More ▼
Press releases
- BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
- BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing
- BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
- BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn® Expanded Access Program at 2024 Annual NEALS Meeting
- BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn® Trial at the 2024 Maxim Healthcare Virtual Summit
- BrainStorm Cell Therapeutics Announces Presentations on NurOwn® at 2024 Annual NEALS Meeting
More ▼